GSK plc SEC filings GLAXF
GSK plc has 1,001 filings in SEC EDGAR's recent list, going back to Aug 1, 2022. Its latest annual report, Form 20-F, was filed on Mar 6, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| 13F-HR | Filing | Nov 5, 2026 | Sep 30, 2026 |
| 144 | Notice of proposed sale | Aug 20, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| 13F-HR | Filing | Aug 13, 2026 | Jun 30, 2026 |
| 13F-HR | Filing | May 14, 2026 | Mar 31, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 6, 2026 | — |
| 13F-HR | Filing | Feb 12, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 5, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Aug 13, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 28, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 7, 2025 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 15, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 4 | Insider transaction | Oct 1, 2024 | Sep 27, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 28, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Feb 9, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 6, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 6, 2024 | — |
| 4 | Insider transaction | Jan 30, 2024 | Dec 7, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Jan 19, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Oct 10, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Sep 11, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jul 20, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | May 16, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 6, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Jan 30, 2023 | — |
| 3 | Initial insider ownership | Jan 30, 2023 | Jan 23, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Jan 20, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jan 20, 2023 | — |
| 3 | Initial insider ownership | Nov 14, 2022 | Nov 7, 2022 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 14, 2022 | — |
| 3 | Initial insider ownership | Nov 4, 2022 | Jun 16, 2021 |
| SC 13D | Ownership over 5% (active) | Nov 4, 2022 | — |
| 4 | Insider transaction | Sep 20, 2022 | Sep 16, 2022 |
| SC 13D/A | Amended ownership over 5% (active) | Sep 20, 2022 | — |
| SC 13D/A | Amended ownership over 5% (active) | Aug 3, 2022 | — |
Showing 39 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GSK (NYSE), GLAXF (OTC)
- Incorporated in
- United Kingdom
- Headquarters
- London
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1131399
- Former names
- GLAXOSMITHKLINE PLC (until May 16, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.